Annual Accounts Payable
$3.52 M
-$71.40 K-1.99%
31 December 2023
Summary:
Imunon annual accounts payable is currently $3.52 million, with the most recent change of -$71.40 thousand (-1.99%) on 31 December 2023. During the last 3 years, it has risen by +$1.27 million (+56.59%). IMNN annual accounts payable is now -41.86% below its all-time high of $6.05 million, reached on 01 December 2010.IMNN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$2.36 M
+$390.60 K+19.83%
30 September 2024
Summary:
Imunon quarterly accounts payable is currently $2.36 million, with the most recent change of +$390.60 thousand (+19.83%) on 30 September 2024. Over the past year, it has increased by +$533.10 thousand (+29.18%). IMNN quarterly accounts payable is now -60.97% below its all-time high of $6.05 million, reached on 01 December 2010.IMNN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMNN Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.0% | +29.2% |
| 3 y3 years | +56.6% | -9.8% |
| 5 y5 years | +16.4% | -40.0% |
IMNN Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -2.0% | +56.6% | -40.6% | +29.2% |
| 5 y | 5 years | -2.0% | +56.6% | -40.6% | +29.2% |
| alltime | all time | -41.9% | +5710.3% | -61.0% | +6720.5% |
Imunon Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.36 M(+19.8%) |
| June 2024 | - | $1.97 M(-16.5%) |
| Mar 2024 | - | $2.36 M(-32.9%) |
| Dec 2023 | $3.52 M(-2.0%) | $3.52 M(+92.4%) |
| Sept 2023 | - | $1.83 M(-30.1%) |
| June 2023 | - | $2.61 M(-34.3%) |
| Mar 2023 | - | $3.97 M(+10.8%) |
| Dec 2022 | $3.59 M(+40.8%) | $3.59 M(+6.4%) |
| Sept 2022 | - | $3.37 M(+40.8%) |
| June 2022 | - | $2.39 M(-31.1%) |
| Mar 2022 | - | $3.47 M(+36.4%) |
| Dec 2021 | $2.55 M(+13.5%) | - |
| Dec 2021 | - | $2.55 M(-2.6%) |
| Sept 2021 | - | $2.62 M(+24.0%) |
| June 2021 | - | $2.11 M(+0.2%) |
| Mar 2021 | - | $2.10 M(-6.2%) |
| Dec 2020 | $2.24 M(-21.6%) | $2.24 M(+3.5%) |
| Sept 2020 | - | $2.17 M(-9.7%) |
| June 2020 | - | $2.40 M(-15.9%) |
| Mar 2020 | - | $2.86 M(-0.2%) |
| Dec 2019 | $2.86 M(-5.2%) | $2.86 M(-27.3%) |
| Sept 2019 | - | $3.94 M(+16.0%) |
| June 2019 | - | $3.39 M(+31.2%) |
| Mar 2019 | - | $2.59 M(-14.4%) |
| Dec 2018 | $3.02 M(-11.6%) | $3.02 M(-4.4%) |
| Sept 2018 | - | $3.16 M(-14.7%) |
| June 2018 | - | $3.70 M(+8.4%) |
| Mar 2018 | - | $3.42 M(0.0%) |
| Dec 2017 | $3.42 M(+18.7%) | $3.42 M(+21.8%) |
| Sept 2017 | - | $2.81 M(-20.8%) |
| June 2017 | - | $3.54 M(-12.5%) |
| Mar 2017 | - | $4.05 M(+40.7%) |
| Dec 2016 | $2.88 M(+1.7%) | $2.88 M(-4.9%) |
| Sept 2016 | - | $3.03 M(+2.6%) |
| June 2016 | - | $2.95 M(+6.7%) |
| Mar 2016 | - | $2.76 M(-2.3%) |
| Dec 2015 | $2.83 M(-18.7%) | $2.83 M(+13.0%) |
| Sept 2015 | - | $2.50 M(-21.8%) |
| June 2015 | - | $3.20 M(-22.1%) |
| Mar 2015 | - | $4.11 M(+18.2%) |
| Dec 2014 | $3.48 M(+139.6%) | $3.48 M(-21.5%) |
| Sept 2014 | - | $4.44 M(+22.6%) |
| June 2014 | - | $3.62 M(+72.1%) |
| Mar 2014 | - | $2.10 M(+44.7%) |
| Dec 2013 | $1.45 M(-37.9%) | $1.45 M(-35.4%) |
| Sept 2013 | - | $2.25 M(+47.7%) |
| June 2013 | - | $1.52 M(-63.6%) |
| Mar 2013 | - | $4.18 M(+78.7%) |
| Dec 2012 | $2.34 M(-41.7%) | $2.34 M(-55.0%) |
| Sept 2012 | - | $5.20 M(+20.8%) |
| June 2012 | - | $4.31 M(+16.1%) |
| Mar 2012 | - | $3.71 M(-7.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $4.01 M(-33.7%) | $4.01 M(+44.6%) |
| Sept 2011 | - | $2.77 M(-16.7%) |
| June 2011 | - | $3.33 M(+0.3%) |
| Mar 2011 | - | $3.32 M(-45.1%) |
| Dec 2010 | $6.05 M(+175.9%) | $6.05 M(+120.5%) |
| Sept 2010 | - | $2.74 M(+26.6%) |
| June 2010 | - | $2.17 M(-6.0%) |
| Mar 2010 | - | $2.30 M(+5.2%) |
| Dec 2009 | $2.19 M(+84.7%) | $2.19 M(-22.8%) |
| Sept 2009 | - | $2.84 M(-9.5%) |
| June 2009 | - | $3.14 M(+68.6%) |
| Mar 2009 | - | $1.86 M(+56.9%) |
| Dec 2008 | $1.19 M(-35.2%) | $1.19 M(-47.0%) |
| Sept 2008 | - | $2.24 M(+70.8%) |
| June 2008 | - | $1.31 M(-47.4%) |
| Mar 2008 | - | $2.49 M(+36.0%) |
| Dec 2007 | $1.83 M(-14.3%) | $1.83 M(+55.6%) |
| Sept 2007 | - | $1.18 M(-54.1%) |
| June 2007 | - | $2.56 M(+20.1%) |
| Mar 2007 | - | $2.13 M(-0.1%) |
| Dec 2006 | $2.14 M(+7.0%) | $2.14 M(+31.5%) |
| Sept 2006 | - | $1.62 M(+28.5%) |
| June 2006 | - | $1.26 M(-11.4%) |
| Mar 2006 | - | $1.43 M(-28.6%) |
| Dec 2005 | $2.00 M(+143.7%) | $2.00 M(+23.0%) |
| Sept 2005 | - | $1.62 M(-2.1%) |
| June 2005 | - | $1.66 M(+4.7%) |
| Mar 2005 | - | $1.58 M(+93.2%) |
| Dec 2004 | $819.20 K(+29.8%) | $819.20 K(-39.5%) |
| Sept 2004 | - | $1.35 M(-7.6%) |
| June 2004 | - | $1.47 M(-26.6%) |
| Mar 2004 | - | $2.00 M(+216.4%) |
| Dec 2003 | - | $631.10 K(0.0%) |
| Sept 2003 | $631.10 K(+27.6%) | $631.10 K(-21.3%) |
| June 2003 | - | $801.70 K(+8.8%) |
| Mar 2003 | - | $736.80 K(-7.2%) |
| Dec 2002 | - | $793.70 K(+60.5%) |
| Sept 2002 | $494.60 K(+239.9%) | $494.60 K(-5.0%) |
| June 2002 | - | $520.90 K(+15.7%) |
| Mar 2002 | - | $450.20 K(+1201.2%) |
| Dec 2001 | - | $34.60 K(-76.2%) |
| Sept 2001 | $145.50 K(+140.5%) | $145.50 K(+16.6%) |
| June 2001 | - | $124.80 K(+126.1%) |
| Mar 2001 | - | $55.20 K(-64.1%) |
| Dec 2000 | - | $153.80 K(+154.2%) |
| Sept 2000 | $60.50 K(-39.5%) | $60.50 K(-42.8%) |
| June 2000 | - | $105.80 K(-54.6%) |
| Mar 2000 | - | $233.10 K(+133.1%) |
| Sept 1999 | $100.00 K(-90.3%) | $100.00 K |
| Sept 1998 | $1.03 M(+68.5%) | - |
| Sept 1997 | $614.20 K(+211.5%) | - |
| Sept 1996 | $197.20 K | - |
FAQ
- What is Imunon annual accounts payable?
- What is the all time high annual accounts payable for Imunon?
- What is Imunon annual accounts payable year-on-year change?
- What is Imunon quarterly accounts payable?
- What is the all time high quarterly accounts payable for Imunon?
- What is Imunon quarterly accounts payable year-on-year change?
What is Imunon annual accounts payable?
The current annual accounts payable of IMNN is $3.52 M
What is the all time high annual accounts payable for Imunon?
Imunon all-time high annual accounts payable is $6.05 M
What is Imunon annual accounts payable year-on-year change?
Over the past year, IMNN annual accounts payable has changed by -$71.40 K (-1.99%)
What is Imunon quarterly accounts payable?
The current quarterly accounts payable of IMNN is $2.36 M
What is the all time high quarterly accounts payable for Imunon?
Imunon all-time high quarterly accounts payable is $6.05 M
What is Imunon quarterly accounts payable year-on-year change?
Over the past year, IMNN quarterly accounts payable has changed by +$533.10 K (+29.18%)